The sharp rise in stock price led to the New York Stock Exchange stopping trading of Babylon common stock. Babylon has not had any discussions with a potential acquirer, according to the Aug. 15 Babylon news release.
By the end of the day Aug. 15, the stock had fallen 5 percent as the company attempted to shut down the speculation, according to The Motley Fool.
The acquisition rumors come after Babylon reported strong second-quarter earnings.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
